Detail
| LncRNA Name | ABHD11-AS1 |
| Synonyms | ABHD11-AS1, LINC00035, NCRNA00035, WBSCR26 |
| Region | GRCh38_7:73735038-73736158 Sequence |
| Ensembl | ENSG00000225969 |
| RefSeq | NR_026690 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, RNAi, Flow cytometry assay, CCK-8 assay, MTT assay etc. |
| Sample | bladder cancer tissues, cell lines (T24, 5637, SW780) |
| Expression Pattern | up-regulated |
| Function Description | ABHD11-AS1 was up-regulated in bladder cancer tissues and cell lines, and ABHD11-AS1 expression level was positively associated with clinicobiological features. Cell proliferation, cell migration and apoptosis were observed by silencing ABHD11-AS1 and overexpression ABHD11-AS1 caused contrary effects. |
| Pubmed ID | 28157695 |
| Year | 2017 |
| Title | Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. |
| External Links |
| Links for ABHD11-AS1 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.